Venetoclax salvage therapy in relapsed/refractory multiple myeloma

Haematologica. 2024 Mar 1;109(3):979-981. doi: 10.3324/haematol.2023.283472.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
  • Humans
  • Multiple Myeloma* / drug therapy
  • Neoplasms, Plasma Cell*
  • Salvage Therapy
  • Sulfonamides*

Substances

  • venetoclax
  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides